Thanks Eire.
I'd like to know when we expect to start the phase 2 EFS study in the US, how many patients do we expect to enroll and what's an estimated time to get results (not including the long-term follow-up obviously). And will the phase 2 completion give us enough data to submit the application for Premarket Approval.
AGM questions to be submitted to the CEO, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$4.85 |
Change
-0.150(3.00%) |
Mkt cap ! $75.19M | |||
| Open | High | Low | Value | Volume |
| $5.00 | $5.00 | $4.84 | $15.32K | 3.146K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 882 | $4.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.20 | 2136 | 2 |
View Market Depth
| Last trade - 15.14pm 25/07/2025 (20 minute delay) ? |
| AVR (ASX) Chart |